
IMCAS China - Dermatology, Plastic Surgery & Aging Science
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to IMCAS China - Dermatology, Plastic Surgery & Aging Science — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
IMCAS China 2026 — Dermatology, Plastic Surgery & Aging Science
IMCAS China 2026 is an international medical congress dedicated to elevating expertise in dermatology, plastic surgery, and aesthetic medicine. The program brings together leading physicians, researchers, and innovators to share evidence-based advances, discuss region-specific clinical approaches, and connect global best practices with evolving trends in China and broader Far East Asia.
Scheduled for Thursday, August 27 to Saturday, August 29, 2026, the congress will take place at W Hotel - The Bund, Shanghai, China. Set within a high-profile international venue, the meeting format is designed for practical learning and professional networking across clinical specialties and industry innovation areas.
Why IMCAS China 2026 matters
IMCAS China 2026 builds on the momentum of the 2025 edition, continuing to unite top specialists—especially those with deep expertise in China—to discuss breakthroughs that resonate both locally and globally. The congress emphasizes approaches tailored to Far East Asian facial harmony and morphology, including technique refinements, combination therapy strategies, and advanced methods in skin rejuvenation.
Core educational themes and what attendees can expect
The congress is positioned as a forward-looking forum for clinicians seeking hands-on skill development and current clinical perspectives in aesthetic practice and aging science. The content includes:
- Live demonstrations led by recognized specialists, focusing on real-world procedures and applications.
- Expert panels for discussion and clinical exchange across dermatology, plastic surgery, and aesthetic medicine.
- Cadaver workshops supporting advanced surgical learning and technique understanding.
- Hands-on courses designed to translate current knowledge into practical daily use.
- Interactive learning through structured programming that blends theory with applied training.
Attendees will also be exposed to cutting-edge technologies and clinical innovations being advanced by Chinese experts, including: energy-based devices, regenerative medicine therapies, AI-guided diagnostics, and cosmeceuticals, among other topics highlighted within the congress scope.
Region-specific focus
A defining strength of IMCAS China 2026 is its region-specific lens on aesthetics and rejuvenation. The congress highlights injectable techniques designed for East Asian facial harmony, along with popular combination therapies in China—helping participants better understand how clinical practice trends are evolving locally while remaining connected to international evidence and technique standards.
Who typically participates
IMCAS China 2026 is designed for clinicians and medical professionals including experienced specialists and emerging practitioners. Based on the congress positioning, the audience includes physicians and medical experts in dermatology, plastic surgery, and related aesthetic fields, alongside researchers and industry innovators contributing to the advancement of safe, modern aesthetic practice.
Conference logistics (from official event details)
- Date: Thursday August 27 – Saturday August 29, 2026
- Venue: W Hotel - The Bund
- City: Shanghai
- Country: China
IMCAS China 2026 offers a platform to track regional trends, enhance clinical capability through practical learning, and strengthen professional connections across China and internationally—supporting collaboration and knowledge exchange throughout the dermatology, plastic surgery, and aging science communities.
Data sheet
| Event Name | IMCAS China 2026 |
| Event Date | Thursday, 27 August 2026 - Saturday, 29 August 2026 |
| Event Status | Upcoming |
| Venue | W Hotel - The Bund |
| City | Shanghai |
| State / Region | Shanghai Municipality |
| Country | China |
| Organizer | IMCAS |
| Official Event Website | imcas.com/en/imcas-china-2026 |
| Event Type | International congress / scientific conference / industry networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Wellness, Health & Fitness; Science & Research; Business Services |
| Audience Reach | Global, with strong China and Asia-Pacific participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium for event facts; low for attendance volume because no official figure was published on the provided source text. |
| Main Purpose of Event | To deliver scientific education, live demonstrations, hands-on learning, and industry networking for dermatology, plastic surgery, and aesthetic medicine professionals. |
IMCAS China 2026 is a specialized congress focused on dermatology, plastic surgery, and aesthetic medicine, hosted in Shanghai at the W Hotel - The Bund. The official event description positions the congress as a high-level forum for evidence-based techniques, live demonstrations, expert panels, cadaver workshops, and hands-on courses, with strong emphasis on China-specific and Far East Asian clinical practice.
The event matters because it sits at the intersection of clinical education, medical innovation, and commercial product adoption in one of the world’s most important aesthetic medicine markets. It attracts physicians, researchers, and industry innovators who influence procurement, product selection, treatment protocols, and the adoption of devices, injectables, cosmeceuticals, regenerative medicine solutions, and AI-enabled clinical tools.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Dermatologists | Private clinics, hospitals, academic medical centers, aesthetic practices | Clinical decision-makers and protocol influencers | High-value buyers of devices, injectables, skin-care lines, and training |
| Plastic surgeons | Hospitals, surgical centers, specialty clinics | Procedure selection, capital equipment, and product adoption | Strong fit for surgical tools, energy-based devices, implants, and regenerative products |
| Aesthetic medicine practitioners | Medical spas, aesthetic clinics, cosmetic practices | Purchasing and treatment design influence | Key buyers for injectables, devices, cosmeceuticals, and patient-journey solutions |
| Clinic owners / practice managers | Independent clinics, chains, medical groups | Budget approval, vendor selection, ROI assessment | Important for supplier contracting and equipment investments |
| Hospital procurement and sourcing teams | Public and private hospitals, surgical networks | Vendor comparison, purchasing approvals, tender management | Relevant for device suppliers, consumables, and clinical systems |
| Distributors and importers | Medical device distributors, cosmetics importers, regional sales partners | Channel development, brand distribution, territory expansion | Critical for manufacturers seeking China and APAC market entry |
| Product and medical affairs teams | Medical device firms, pharma, aesthetics companies | Clinical evidence, launch support, KOL engagement | Useful for scientific selling and product education |
| Researchers and academic leaders | Universities, hospitals, research institutes | Protocol validation, publication influence, guideline shaping | Important for evidence-based product positioning and KOL programs |
| Industry sponsors and exhibitors | Aesthetic device companies, pharma brands, skincare manufacturers | Commercial partnerships, education sponsorship, product promotion | Relevant for business development and channel sales |
| Medical consultants / advisors | Independent KOLs, advisory board members, trainers | Influence adoption and peer recommendation | Very useful for referral-based medical sales |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Shanghai | High | High | Major medical, commercial, and aesthetic services hub |
| Host region: Shanghai Municipality / East China | Very high | High | Strong local and regional clinic, hospital, and distributor participation expected |
| Nearby business hubs | Jiangsu, Zhejiang, Beijing, Guangdong | High | Likely draw from large urban medical and commercial markets |
| National reach | Hospitals, clinics, distributors, academies across China | Very high | Official site emphasizes expertise from China-based specialists and innovators |
| International reach | Asia-Pacific, Europe, Middle East, Americas | Medium to high | Testimonials on the official page show participation from multiple countries |
| Trade corridor relevance | China importers, APAC distributors, cross-border brand owners | High | Important for commercial partners seeking distribution and market access |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The congress is positioned as an international scientific and commercial forum with participation from China and overseas markets. |
| Secondary reach | Asia-Pacific leading, China-dominant | The event content is tailored to local practice and East Asian morphologies while staying globally relevant. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Shanghai Ninth People's Hospital | Hospital / clinical buyer | Large surgical and dermatology center likely relevant to procedures, training, and product adoption | sjtu.edu.cn | Department Head, Procurement Manager, Medical Director | Strong Market Fit, Attendance Not Confirmed |
| Ruijin Hospital | Hospital / clinical buyer | Academic hospital environment with dermatology and surgical influence | ruijinhospital.com | Chief Physician, Equipment Director, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
| Fudan University Shanghai Cancer Center | Hospital / academic medical buyer | Clinical research culture and specialty procedures support event relevance | shca.org.cn | Clinical Director, Research Lead, Purchasing Director | Strong Market Fit, Attendance Not Confirmed |
| Peking Union Medical College Hospital | Hospital / academic buyer | Top-tier medical institution with specialist decision-makers and training influence | pumch.cn | Department Chair, Tender Buyer, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| West China Hospital, Sichuan University | Hospital / academic buyer | Major tertiary center with broad specialty and procurement needs | wchscu.cn | Procurement Manager, Surgery Director, Clinical Operations Lead | Strong Market Fit, Attendance Not Confirmed |
| Shanghai Skin Disease Hospital | Dermatology hospital buyer | Highly aligned with clinical dermatology, devices, and skin rejuvenation solutions | skin168.com | Dermatology Director, Purchasing Head, Medical Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| Aesthetic clinic chains in Shanghai | Clinic chain buyer | Likely purchasers of injectables, lasers, skincare, and patient experience tools | varies by chain | CEO, COO, Purchasing Manager, Medical Director | Strong Market Fit, Attendance Not Confirmed |
| Bausch Health / Solta Medical | Device manufacturer / sponsor-side buyer | Energy-based device ecosystem aligns with event themes | bauschhealth.com | Business Development, Regional Sales Director, Product Manager | Strong Market Fit, Attendance Not Confirmed |
| AbbVie / Allergan Aesthetics | Aesthetics company | Injectables and aesthetics portfolio strongly aligned to audience needs | abbvie.com | Brand Manager, Medical Affairs, Sales Director | Strong Market Fit, Attendance Not Confirmed |
| Galderma | Aesthetics / dermatology company | Strong relevance to injectables and dermatology professionals | galderma.com | Country Manager, Product Director, Key Account Manager | Strong Market Fit, Attendance Not Confirmed |
| Merz Aesthetics | Aesthetics company | Relevant to facial aesthetics, injectables, and medical education | merz.com | Regional Marketing, Medical Education, Business Development | Strong Market Fit, Attendance Not Confirmed |
| L'Oréal Dermatological Beauty | Skincare / cosmeceuticals buyer | Relevant to cosmeceuticals and skin health market segments | loreal.com | Category Manager, Product Marketing, Medical Liaison | Strong Market Fit, Attendance Not Confirmed |
| Beijing Aiyou Hospital / private specialty hospitals | Specialty hospital buyer | Likely interested in surgical tools, clinical devices, and procedures | varies by institution | Procurement Lead, Surgeon, Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| Medical device distributors in East China | Distributor / channel buyer | Distribution partnerships are highly relevant for market access | varies by company | General Manager, Channel Director, Import Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Medical Director / Clinical Director | Clinical Leadership | Director / VP | Owns treatment standards, product approval, and clinical protocols |
| 2 | Chief Procurement Officer / Procurement Director | Procurement | Director / C-level | Controls vendor onboarding, pricing, and purchasing decisions |
| 3 | Plastic Surgeon / Dermatologist | Clinical | Senior individual contributor | Primary end-user and influencer for product selection |
| 4 | Practice Owner / Clinic Owner | Executive / Operations | Owner / Founder | Approves capital purchases and revenue-generating services |
| 5 | Operations Director / Clinic Operations Manager | Operations | Director / Manager | Oversees workflow, patient experience, and vendor implementation |
| 6 | Medical Affairs Manager / Product Manager | Medical Affairs / Product | Manager / Senior Manager | Supports scientific education, launches, and clinical adoption |
| 7 | Distributor / Channel Director | Commercial / Channel Sales | Director | Critical for market access, regional expansion, and partnership deals |
| 8 | R&D / Innovation Lead | Research and Development | Manager / Director | Influences adoption of new technologies and formulations |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core audience includes hospitals and specialty medical providers | Clinical buyers, department heads, procurement teams |
| 2 | Medical Devices | Strong fit for aesthetic devices, energy-based platforms, and surgical tools | Device sales, distributor recruitment, capital equipment buyers |
| 3 | Pharmaceuticals | Relevant to injectables, dermatology therapies, and medical affairs | Brand teams, medical affairs, launch support |
| 4 | Cosmetics | Skincare and cosmeceutical exposure is a major event theme | Category managers, brand owners, channel partners |
| 5 | Research | Scientific congress format attracts researchers and evidence builders | KOL engagement, clinical validation, education partnerships |
| 6 | Biotechnology | Regenerative medicine and advanced therapies are highlighted | Innovation partnerships and early-stage product evaluation |
| 7 | Information Technology & Services | AI-guided diagnostics and digital workflows are mentioned on the official site | AI, clinical software, workflow tools, imaging platforms |
| 8 | Import & Export | Channel access, cross-border sales, and distribution are relevant | Distributors, importers, regional expansion partners |
| 9 | Management Consulting | Market strategy, medical group growth, and commercialization support | Advisory services for clinics, device companies, and distributors |
| 10 | Retail | Relevant for skincare brands and consumer-facing aesthetics products | Category buyers, merchandising, and omnichannel brand teams |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Unavailable | Official page content provided did not publish an attendance figure | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed in provided source text | Unavailable | Sponsor list and exhibit details were referenced, but no count was published in the supplied text | Use sponsor list page for verification if needed. |
| Buyer count | Not publicly confirmed | Unavailable | No official buyer list was included in the provided source text | Likely mixed clinical and industry attendance. |
| Speaker count | Not publicly confirmed in provided source text | Unavailable | Official program page referenced, but no count extracted from supplied text | Likely multi-track scientific agenda. |
| Historical attendance | Not used | Not required | Current event page content supplied | No reliable prior-year attendance figure was provided. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Clinical education | Need for practical, evidence-based training | Workshops, demonstrations, peer learning | Training programs, clinical kits, educational sponsorships |
| Aesthetic devices | Demand for energy-based and procedural platforms | Live demos and product comparisons | Lasers, RF, ultrasound, skin rejuvenation systems |
| Injectables | Safe, effective facial aesthetic solutions | Scientific sessions and KOL-led education | Fillers, toxin, skin boosters, combination protocols |
| Regenerative medicine | New approaches to healing and rejuvenation | Innovation showcases and scientific discussion | Biologic adjuncts, PRP-related tools, regenerative therapies |
| AI and digital diagnostics | Need for better diagnostics and workflow efficiency | Tech showcase and expert panels | AI imaging, decision support, practice software |
| Cosmeceuticals | Demand for skin health, maintenance, and post-procedure care | Product sampling, clinical evidence, brand education | Dermocosmetics, post-care products, nutraceuticals |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event attracts clinicians, clinics, hospitals, distributors, and brands directly involved in purchasing and adoption. |
| Decision-maker availability | High | Medical directors, owners, procurement leads, and distributor executives are highly likely attendees. |
| Data collection potential | Medium | No public attendee list was provided in the official text, but sponsor, speaker, and program pages may improve list building. |
| Apollo targeting potential | Very High | Strong fit across hospitals, clinics, medical devices, pharmaceuticals, cosmetics, and distributors. |
| Geographic targeting potential | High | Shanghai and broader China/APAC targeting are highly actionable for outreach and account selection. |
| Best outreach approach | High-touch, educational, clinically relevant | Lead with scientific credibility, procedure outcomes, and commercial ROI. |
| Overall lead quality | High | Strong mix of clinical buyers, commercial buyers, and channel partners. |
| Best use case | Attendee list sales, account targeting, exhibitor outreach, sponsor prospecting | Well suited to B2B sales teams targeting medical and aesthetics buyers. |
| Limitations / risks | No confirmed public attendance total or current attendee list in supplied text | Requires careful qualification of prospecting targets versus confirmed participants. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care, Medical Devices, Pharmaceuticals, Cosmetics, Biotechnology, Information Technology & Services, Import & Export, Research | Capture clinics, hospitals, brands, distributors, and innovation stakeholders |
| Departments | Procurement, Operations, Medical Affairs, Clinical, Business Development, Product, Marketing | Target both buyers and commercial influencers |
| Seniority | Manager, Senior Manager, Director, VP, CXO, Owner | Prioritize decision-makers and budget holders |
| Job titles | Medical Director, Clinic Owner, Procurement Manager, Purchasing Director, Operations Director, Product Manager, Channel Director, Business Development Director, Dermatologist, Plastic Surgeon | Align outreach with clinical and commercial decision-makers |
| Geography | China, Shanghai Municipality, East China, Hong Kong, Singapore, South Korea, Japan, Southeast Asia | Match expected attendee and distributor geography |
| Employee size | 11-50, 51-200, 201-500, 501-1,000, 1,000+ | Covers clinics, hospital groups, and medical manufacturers |
| Keywords | aesthetic medicine, dermatology, plastic surgery, injectables, energy-based devices, cosmeceuticals, regenerative medicine, AI diagnostics, clinic, medical spa | Improve account and contact precision |
| Company type | Private companies, hospitals, clinic chains, distributors, medical brands, research institutions | Focus on entities with purchasing authority or market access |
| Revenue / funding filters | Mid-market and enterprise; public companies where applicable | Prioritize organizations with budget and scaling potential |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| IMCAS China 2026 official event page | Official organizer source | Event name, dates, venue, city, country, congress purpose, format, themes, and attendee testimonials | High |
| IMCAS home page | Official organizer source | Organizer positioning, global congress network, and broader scientific focus | High |
| Official IMCAS China page text supplied in prompt | Primary source extract | Scientific themes, audience description, program format, and venue details | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to IMCAS China - Dermatology, Plastic Surgery & Aging Science — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.